Membranous Nephropathy
Patients with diabetes on kidney biopsy may have non-diabetic kidney disease findings
More than half of patients with diabetes undergoing kidney biopsy had additional findings other than diabetic kidney disease, according to published data from the Cleveland Clinic Florida.
Cardiovascular, thromboembolic events more closely tied to kidney vs. glomerular disease
Incident cardiovascular and thromboembolic events may be more closely linked to the severity of kidney disease than with glomerular disease subtype, according to results of a prospective study.
Urinary plasminogen may be independently linked to risk of progression to ESKD
Urinary plasminogen and the ratio of measured to expected plasminogen may be independently linked to the risk of progression to end-stage kidney disease, data show.
Some proteins may predict focal segmental glomerulosclerosis recurrence post-transplant
PHILADELPHIA — There are 32 proteins that could be of interest to help predict focal segmental glomerulosclerosis recurrence in patients with kidney disease, according to presented data.
Human Immunology Biosciences receives FDA orphan drug designation for felzartamab
The FDA has granted orphan drug designation to felzartamab, an investigational agent being developed by Human Immunology Biosciences to treat primary membranous nephropathy, according to a press release.